Multitarget AD-IN-8

Multitarget AD-IN-8 is a blood-brain barrier-penetrant, orally active multitarget inhibitor. Multitarget AD-IN-8 inhibits abnormal Tau phosphorylation at Thr181 and Ser396 sites and attenuates NF-κB phosphorylation. Multitarget AD-IN-8 downregulates BACE1 expression to reduce Aβ production, inhibits the Bax/Bcl-2 pathway, and suppresses Caspase-1 activation. Multitarget AD-IN-8 attenuates p38, ERK1/2, and JNK phosphorylation and inhibits Aβ25-35-induced Apoptosis. Multitarget AD-IN-8 exhibits neuroprotective effects against Aβ25-35-induced injury, ameliorates learning and memory deficits in AD mouse models, and alleviates hippocampal neuronal pathological damage. Multitarget AD-IN-8 can be used for research on Alzheimer's disease.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • Formel: C31H34N2O8
  • Molecular Weight:562.61
  • Speicherung:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biologische Aktivität
  • Chemical Information
  • Protokoll
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs

Alle NF-κB Isoform-spezifische Produkte anzeigen

More

Alle Beta-secretase Isoform-spezifische Produkte anzeigen

More

Alle Bcl-2 Family Isoform-spezifische Produkte anzeigen

More

Alle p38 MAPK Isoform-spezifische Produkte anzeigen

More

Alle ERK Isoform-spezifische Produkte anzeigen

More

Alle JNK Isoform-spezifische Produkte anzeigen

More
MOQ
Minimum order quantity
100 mg

Angebot einholen Auf Lager

Other size
Angebot einholen
Please select quantity
Amount: USD 0.00